Glaxosmi. Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE159A01016
  • NSEID: GLAXO
  • BSEID: 500660
INR
2,485.85
42.75 (1.75%)
BSENSE

Feb 06

BSE+NSE Vol: 77.27 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryGlaxosmi. Pharma VS Pharmaceuticals & Biotechnology
 
1D
1.75%
0.32%
1W
3.69%
1.59%
1M
0.15%
-1.74%
YTD
0.6%
-1.92%
1Y
9.69%
7.07%
3Y
100.71%
38.13%
5Y
73.66%
64.75%
10Y
51.08%
239.52%
  • Stock Absolute Returns
  • Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-4.49%
0%
-4.49%
6 Months
-8.33%
0%
-8.33%
1 Year
9.69%
0%
9.69%
2 Years
0.77%
1.95%
2.72%
3 Years
100.71%
5.79%
106.5%
4 Years
58.1%
8.84%
66.94%
5 Years
73.66%
10.91%
84.57%

Latest dividend: 12 per share ex-dividend date: Nov-07-2024

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the last 1 year and longer periods

2
Quartile
quartile-2
QTD
0.6%
4
Quartile
quartile-4
Sep-Dec
-6.99%
4
Quartile
quartile-4
Jun-Sep
-21.48%
2
Quartile
quartile-2
1Y
12.77%
2
Quartile
quartile-2
2025
9.98%
3
Quartile
quartile-3
2024
18.41%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the last 1 year and longer periods

2
Quartile
quartile-2
QTD
0.6%
3
Quartile
quartile-3
Sep-Dec
-6.99%
4
Quartile
quartile-4
Jun-Sep
-21.48%
1
Quartile
quartile-1
1Y
12.77%
1
Quartile
quartile-1
2025
9.98%
3
Quartile
quartile-3
2024
18.41%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the last 1 year and longer periods

2
Quartile
quartile-2
QTD
0.6%
3
Quartile
quartile-3
Sep-Dec
-6.99%
4
Quartile
quartile-4
Jun-Sep
-21.48%
2
Quartile
quartile-2
1Y
12.77%
2
Quartile
quartile-2
2025
9.98%
3
Quartile
quartile-3
2024
18.41%
Click on any of the quartiles for detailed breakdown
stock-summaryRisk Adjusted Returns v/s
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available